SPY421.97-0.14 -0.03%
DIA338.65-2.11 -0.62%
IXIC14,161.35+121.67 0.87%

--HC Wainwright Adjusts Mirati Therapeutics' Price Target to $251 from $255, Keeps Overweight Rating

05/10/2021 05:16

09:12 AM EDT, 05/10/2021 (MT Newswires) -- (MT Newswires covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www.mtnewswires.com/contact-us)

Price: 148.02, Change: +4.02, Percent Change: +2.79